Participate in a Study

NN8022-4180 Study

Study Type


Study Purpose

The rate of obesity in adolescents continues to rise. Currently, there is only one drug approved for the management of obesity in adolescents; however the drug is not suitable for everyone. There is a need for more options to help obese adolescents lose weight.

The NN8022-4180 research study will assess the safety and effectiveness of a study drug (Liraglutide) for use in the management of obesity in adolescents.

About the Study

The study drug is approved by the U.S Food and Drug Administration for adults as a treatment option for weight loss. Researchers at Pennington Biomedical will assess the safety and effectiveness of the same drug in an adolescent population.

Study Design

Number of Visits:

  • 1 screening visit
  • Up to 30 study visits to the Pennington Biomedical clinic over 82 weeks


  • Health measurements (blood pressure, pulse, height, weight, etc.)
  • Physical examination
  • Questionnaires
  • ECG test to determine heart health
  • Blood tests

Study Qualifications

To qualify for this research study, participants should:

Study Duration

Participation in this research study will last approximately 1.5 years.


Compensation of up to $980 is offered for completion of this study.

Study Contact

Parents: To see if your 12-17 year old qualifies for this research study, you or a guardian must complete the online screening form below on his or her behalf. You may also call 225-763-3000 or email

If you think you may be eligible, please click the button below to screen online.

Please do not fill out this questionnaire for anyone other than yourself unless you are their legal guardian.
If you know someone who may be interested please direct them to the site or have them call us directly at 225-763-3000.

If you’re 18 or older, there may be other studies that you can join. Click here to find out about these studies or call 225-763-3000 to learn how you can be a volunteer!

If you don't see a trial that fits your interests or needs, click here to complete a questionnaire and we will contact you about any future trials for which you may qualify.